ArticleCureus2026
Obstructive Jaundice Due to Periportal Tuberculous Lymphadenopathy in a Patient With Multidrug-Resistant (MDR) Tuberculosis: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extrapulmonary tuberculosis is a common manifestation of tuberculosis, with lymph node involvement being the most frequent form. Among its presentations, periportal lymph node involvement leading to obstructive jaundice is extremely uncommon. Jaundice developing during anti-tubercular therapy (ATT) is frequently ascribed to drug-induced hepatotoxicity, which may contribute to delays in accurate diagnosis. We report a 17-year-old male with multidrug-resistant (MDR) lymph node tuberculosis who presented with progressive jaundice and right upper quadrant abdominal pain. Laboratory evaluation showed marked conjugated hyperbilirubinemia and cholestatic enzyme elevation. Ultrasonography, contrast-enhanced computed tomography (CECT), and magnetic resonance cholangiopancreatography (MRCP) revealed a large periportal and peripancreatic coalescent lymph nodal mass compressing the common bile duct (CBD), causing upstream biliary dilatation. Differential diagnoses included drug-induced hepatitis and cholangiocarcinoma, but radiology favored tuberculous lymphadenitis. The patient underwent percutaneous transhepatic biliary drainage (PTBD), with significant clinical improvement. He was subsequently restarted on the all-oral longer MDR regimen under careful monitoring. Obstructive jaundice due to tuberculous lymphadenopathy is a rare but important entity that may mimic drug-induced hepatitis or malignancy. Early imaging, biliary decompression, and individualized ATT modification are crucial. This case also highlights the rise and fall pattern associated with evolving drug resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.